Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 563 of 1,261
  1. US 9987262

    Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

    Akebia Therapeutics, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  2. US 9987264

    Method and composition for treating a serotonin receptor-mediated condition

    VANDA PHARMACEUTICALS INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  3. US 9987241

    Enzyme conjugate and prodrug cancer therapy

    The Board of Regents of the University of Oklahoma · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  4. US 9987211

    Sunless tanning compounds and compositions

    Regents of the University of Minnesota · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  5. US 9986723

    Screen and use of therapeutics for pancreatic ductal adenocarcinoma

    The Board of Regents of the University of Texas System · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  6. US 9987242

    Treatment of Levodopa-induced Dyskinesias

    Northwestern University · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  7. US 9982309

    Method for treating cell proliferation related disorders

    Agios Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  8. US 9982263

    Conserved HBV and HCV sequences useful for gene silencing

    Alnylam Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  9. US 9980634

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted May 29, 2018 · Expires May 24, 2038

    granted
  10. US 9982265

    Inhibition of Bruton's tyrosine kinase (Btk) in the lung to treat severe lung inflammation and lung injury

    The Board of Regents of the University of Texas System · Granted May 29, 2018 · Expires May 24, 2038

    granted
  11. US 9982259

    Transthyretin allele selective UNA oligomers for gene silencing

    ARCTURUS THERAPEUTICS, INC. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  12. US 9982245

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Therapeutics, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  13. US 9982236

    Cell populations, methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  14. US 9982013

    Readily isolated bispecific antibodies with native immunoglobulin format

    REGENERON PHARMACEUTICALS, INC. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  15. US 9981999

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted May 29, 2018 · Expires May 24, 2038

    granted
  16. US 9982025

    Monomeric griffithsin tandemers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2018 · Expires May 24, 2038

    granted
  17. US 9981961

    Deoxycytidine kinase inhibitors

    The Regents of the University of California · Granted May 29, 2018 · Expires May 24, 2038

    granted
  18. US 9981944

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  19. US 9981067

    Biomimetic hybrid gel compositions and methods of use

    BIOACTIVE REGENERATIVE THERAPEUTICS, INC. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  20. US 9981238

    Apparatus and methods for making nanosomes loaded with nucleic acid

    Aphios Corporation · Granted May 29, 2018 · Expires May 24, 2038

    granted
  21. US 9981043

    Analgesic conjugates

    Regents of the University of Minnesota · Granted May 29, 2018 · Expires May 24, 2038

    granted
  22. US 9981034

    Compositions and methods for vaccination against influenza A virus

    SOUTH DAKOTA BOARD OF REGENTS · Granted May 29, 2018 · Expires May 24, 2038

    granted
  23. US 9980992

    Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses

    Northwestern University · Granted May 29, 2018 · Expires May 24, 2038

    granted
  24. US 9980980

    Compounds, compositions and methods for protecting brain health in neurodegenerative disorders

    Amazentis SA · Granted May 29, 2018 · Expires May 24, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.